1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Chronic Disease

Chronic Diseases: Latest Market Statistics and Trends

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
5 votes

Global Chronic Disease Treatment Report

A chronic disease is a long-lasting human health condition or pathology that can be controlled but not yet cured by medical assistance. Generally, a disease is considered chronic when lasting for more than three months. In the United States, 7 deaths out of 10 are caused by a chronic pathology making it the leading cause of deaths in the country.

Chronic diseases include stroke, cerebrovascular disease, cancers, asthma, chronic obstructive pulmonary disease (COPD), diabetes, arthritis, and infectious diseases such as hepatitis and HIV. Many of these can ultimately be fatal. Non-communicable chronic diseases (NCDs), which do not transmit from person to person account for the highest global levelof disease burden. Annually NCDs kill more than 38 million people worldwide. About three quarters of NCD deaths occur in low- and middle-income countries.

Key Segments

Key types of chronic diseases include:

Cardiovascular diseases (CVDs) – A group of disorders of the heart and blood vessels. CVDs include coronary heart disease, cerebrovascular disease, peripheral arterial disease, congenital heart disease, deep vein thrombosis and pulmonary embolism. Heart attacks and strokes are usually acute events associated with CVDs. CVDs are the most common cause of death globally. In a recent year, more than 15 million people died from CVDs, accounting for 31% of all deaths globally. The market for cardiovascular therapeutic drugs is worth about $180 billion.

Cancers– A group of diseases caused by uncontrolled division of cells. There are more than 120 types of cancers affecting humans, of which the most common are breast cancer, prostate cancer, colorectal cancer, lung cancer and cervical cancer. Cancers are the second most common cause of death globally. In a recent year, cancer caused over 8 million deaths. Lung cancer, liver cancer, stomach cancer, colorectal cancer and breast cancer are the cancers associated with high mortality rates. The anti-cancer drug market is worth more than $100 billion.

Chronic respiratory diseases (CRDs) – Diseases of airways and other structures of lungs. The most prevalentCRDs are COPD, asthma, occupational lung diseases and pulmonary hypertension. Tobacco smoking and air pollution are the main causes of CRDs. Globally about 4 million people die annually due to CRDs. The global market for drugs to treat COPD and asthma, the two most common CRDs, is worth more than $25 billion.

Diabetes– A chronic disease which leads to increasedblood glucose levels.The population diagnosed with diabetes reached more than 420 million in 2014 from around 105 million in 1980.The prevalence of diabetes increased especially sharplyin middle- and low-income countries. In a recent year, about 1.5 million deaths were directly caused by diabetes and another 2.2 million deaths were attributable to high blood glucose. By 2030, diabetes is predicted to be the seventh leading cause of death globally.

Regional Market Shares

Major regions forchronic diseasetreatment include North America, Europe and Asia.

North America is the largest market for chronic diseasetreatments. Good healthcare access, favorable reimbursement policies and high levels of adoption of premium priced drugs makes this region occupy the largest part of the market. The USA, where heart disease accounts for one in seven deaths andmore than 1500 people die from cancer every day is the largest market in North America for treatments for chronic diseases.

Read more »

You might be interested in these related markets:

24/7 Customer Support

Talk to Sam

+33 4 37 65 17 06

130 Reports
Demographic, Forecast, Demand
340 Statistics
Demographic, Environment, Demand
980 Reports
Demographic, Demand, Social Conditions
2500 Statistics
Demographic, Environment, Social Conditions
94 Reports
Demographic, Demand, Forecast
220 Statistics
Demographic, Environment, Social Conditions
55 Reports
Demographic, Demand, Social Conditions
160 Statistics
Demographic, Environment, Market Size
180 Reports
Demographic, Social Conditions, Forecast
210 Statistics
Demographic, Environment, Social Conditions
92 Reports
Demographic, Demand, Forecast
170 Statistics
Demographic, Environment, Social Conditions
150 Reports
Demographic, Demand, Social Conditions
350 Statistics
Demographic, Environment, Social Conditions
78 Reports
Demographic, Social Conditions, Forecast
210 Statistics
Demographic, Environment, Social Conditions
34 Reports
Demographic, Social Conditions, Demand
250 Statistics
Demographic, Environment, Social Conditions
12 Reports
Demographic, Demand, Company
23 Statistics
Demographic, Environment, Demand
Search in Chronic Disease Industry (About 21000 reports)
Parent industry: Pathology
Related industries: Cancer, Mental Health

About 2300 reports

Purchase Reports From Reputable Market Research Publishers
(From € 409 - € 20000)

Kidney/Renal Function Test Market by Product, Type, Blood Test, End User - Global Forecast to 2022

Kidney/Renal Function Test Market: Global Forecast until 2022

  • € 5045
  • Industry report
  • December 2017
  • by MarketsandMarkets

Kidney Function/Renal Function market is projected to grow at a CAGR of 6.1%.The global kidney function tests market is expected to reach USD 790.1 million by 2022 from USD 586.5 million in 2017 at a CAGR ...

Interventional Cardiology Devices Market: Global Foreca ... € 5045 December 2017

Orthopedic Braces and Supports Market: Global Forecast ... € 5045 September 2017

Bioabsorbable Stent/Bioresorbable Scaffold Market: Glob ... € 5045 August 2017

Thrombectomy Devices Market: Global Forecasts until 202 ... € 5045 April 2017

Insulin Delivery Devices Market: Global Forecast until ... € 5045 April 2017

Insulin Delivery Devices Market: Global Forecast until ... € 5045 April 2017

Active Implantable Medical Devices Market: Global Forec ... € 5045 April 2017

Blood Flow Measurement Devices Market: Global Forecast ... € 5045 March 2017

Neurovascular Devices/Interventional Neurology Market: ... € 5045 March 2017


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on